Laboratories are an essential part of effective modern healthcare. They provide clinicians with vital information that helps them make life-saving decisions, diagnose conditions and monitor patient treatment.
Pediatric laboratory medicine plays a minor role in the large field of laboratory medicine. This may be due to the low incidence of rare diseases, which are a major task of pediatric medicine, but also to the small number of pediatric samples in routine laboratory medicine overall. Since most diagnostic laboratories do receive pediatric samples now and then, it is essential that there are primary…
A fully automated clinical microbiology laboratory system went into service at Heidelberg University Hospital this April. Produced by medical technology firm BD Life Science, this first installation at a German university hospital will play a major role in a study exploring the potential benefits of lab automation in containing the spread of pathogens in a hospital.
Jens Hahn MD is an Internal Medicine and Intensive Care Specialist who works with the international, independent, medical humanitarian organisation Médecins Sans Frontières (MSF in English: Doctors Without Borders). Here he describes his work in Afghanistan and South Sudan, and the use of rapid diagnostic tests in the field.
The yuck factor may be an effective tool for boosting hand hygiene compliance among health care workers, according to a study at Henry Ford Hospital in Detroit.
Bioserveur/Mesanalyses.fr connects 1,400 laboratories, 130 healthcare facilities and 15,000 doctors for sharing information.
The Syndicat des Biologistes (SDB) and the Syndicat National des Biologistes des Hôpitaux (SNBH) are refounding the leading event in Medical Biology: the 60th edition of JIB and the 45th Colloque National des Biologistes will be held this year in Paris Expo Porte de Versailles, Hall 4.
With more than 30 years’ experience developing pioneering high quality, cost effective Quality Control solutions for the IVD market Randox has designed their Acusera range of third party controls to simplify QC practice for labs of all sizes. The following outlines frequent complaints that arise in the lab & solutions we can offer to ensure you no longer quietly complain about your QC.
Professor Klaus Kayser, former Head of the Institute of Pathology at Heidelberg University Hospital’s Thorax Clinic, may be retired but he continues to be a leading figure in his discipline, a visionary, famous for this critical and ‘out of the box’ thinking. During the run-up to the European Congress on Digital Pathology (ECDP), we asked the expert about telemedicine and standards and,…
Healthcare is going digital. No doubt about it, Prof. Hufnagl predicts. Information and communication technologies have gone beyond moving data from one place to the other; they are triggering stellar improvements in healthcare: diagnoses are becoming ever more precise, therapies ever more personalised. The extent to which the individual clinical disciplines have progressed in their technological…
Whilst digital pathology has the potential to deliver more precise diagnostics, there remain a number of barriers to its widespread implementation.
Strictly speaking, digital pathology has not yet resulted in any groundbreaking changes for clinical diagnostics. The conventional light microscope introduced to pathology around 100 years ago continues to be the most important tool for pathologists.
Pathologists in Utrecht step away from the microscope as the first fully digital workflow goes live for primary diagnostics. ‘The whole world wants to stop by and see the show,’ said Paul van Diest MD, who leads the Department of Pathology at the Utrecht University Medical Centre.
As laboratories in Europe shift to systems for digital pathology, they must ensure the technology not only works, but works for them, says Dr Liron Pantanowitz, director of pathology informatics at University of Pittsburgh Medical Center (UPMC).
Harnessing the potential of digital pathology is taking research into new and more efficient biomarkers to a new level. By combining strategic planning with the latest digital pathology technology, high quality tissue microarrays for biomarker research are being produced.
Mobile technology could prove an important catalyst in helping take digital pathology onto a new level in delivering clinical diagnostics.
In a study of 436 breast cancer cases with 28 years of survival data histo-pathologists from Karolinska Institute, Stockholm, Sweden shows that protein tissue-based biomarker data are at least as good as gene expression assays.
Though it is the underlying science that drives diagnosis and treatment decisions, pathology is an often overlooked field. As part of the health continuum, as the turning point for treatment, as a new source for research and discovery – in all these ways, the power of pathology has gone unnoticed. However, the industry is slowly coming to realize its potential in transforming care, knows Hans…
A UK-based neuropathologist has highlighted how the digitisation of pathology will play a pivotal role in taking patient care on to a new and more efficient level. Speaking in a recent Webinar under the heading The Adoption and Benefits of Digital Pathology for Primary Diagnosis, Dr Daniel du Plessis also noted how the digital era would raise the profile of pathology and ‘bring it out of the…
Histopathologists play key roles in diagnosing disease entities and determining biomarkers related to the prognosis and response to specific therapy of malignant tumours. Report: Bela Molnar
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Insulin deficiency and hyperglycemia are two well-known culprits behind diabetes, both of which are reflected in blood glucose concentrations. Now, researchers are working to create ultrasensitive lab-on-a-chip devices to quickly measure glucose concentrations with the goal of developing device for early diagnosis and prevent of diabetes.
Last year, scientists at the University of California San Francisco (UCSF) revealed that by measuring the proportion of both immune and cancerous cells in tumours, or ‘tumour purity,’ clinicians could more precisely predict the success of certain precision therapies. A key aspect of the discovery was access to over 10,000 samples constituting 21 different cancers.
No self-respecting TV crime series is without a pathologist – but the fictitious pathologist who incessantly solves crimes has little to do with reality.
At a recent focus meeting held in Berlin by the Association of Accredited Laboratories in Medicine, Dr Andreas Weimann, managing director at the Laboratory Berlin – Charité Vivantes Services, spoke of the challenges that laboratories working with hospitals face due to the management of pathogens and the diagnosis of infections.